Further, to the best of our knowledge, so far only one pilot study investigated whether epigenetic alterations of NR3C1 impact the outcome of exposure-based psychotherapy for PTSD and/or are reversible by effective treatment [25]. The gene discussed is NR3C1; the disease is post-traumatic stress disorder.